| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP,General Counsel, Secretary | EVP & General Counsel
1 company
Austin D. Kim last filed a Form 4 in January 2024, as EVP,General Counsel, Secretary at ACAD. From December 2019 to January 2024, the filings on record show 0 open-market purchases and 15 sales. Austin D. Kim's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Austin D. Kim a middling insider score of 66/100, based on 11 past trades. Over a 12-month horizon, 72.7% of those trades were profitable, with an average 12-month return of +8.0%.
At the last filing, the largest reported position was 46,901 shares of ACAD. The ACAD filings lean toward selling, a net 54,135 shares.
Shares as reported in the last Form 4 for each company; the most recent is from January 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2021 | ACAD Acadia Pharmaceuticals Inc | EVP & General Counsel | Sell | 2,107 | $50.61 | $106,635.27 | -17.5% | -62.2% | -54.0% | |
| Jan 6, 2021 | ACAD Acadia Pharmaceuticals Inc | EVP & General Counsel | Sale+OE | 678 | $53.34 | $36,164.52 | -10.9% | - | - | |
| Oct 27, 2020 | ACAD Acadia Pharmaceuticals Inc | EVP & General Counsel | Sale+OE | 8,750 | $45.10 | $394,636.38 | -69.4% | - | - | |
| Apr 30, 2020 | ACAD Acadia Pharmaceuticals Inc | EVP & General Counsel | Sale+OE | 1,072 | $49.22 | $52,763.84 | -30.5% | - | - | |
| Dec 11, 2019 | ACAD Acadia Pharmaceuticals Inc | EVP & General Counsel | Sale+OE | 17,500 | $45.06 | $788,576.25 | -97.2% | - | - |